| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |